Market Overview
The Global Isothermal Nucleic Acid Amplification Technology the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2024-2031. The integration of NAAT with an appropriate identification medium resulted in more elevated sensitiveness, particularity and quick disorder diagnosis. The growing cases of infectious diseases, market developments and increasing geriatric population is boosting the global isothermal nucleic acid amplification technology market growth during the forecast period.
Market Scope
Metrics | Details |
CAGR | 11.1% |
Size Available for Years | 2021−2030 |
Forecast Period | 2024−2031 |
Data Availability | Value (USD) |
Segments Covered | Product Type, Applications, Technology, End User and Region |
Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
Fastest Growing Region | Asia-Pacific |
Largest Region | North America |
Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Type Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis key Insights. |
To know more Insights - Request Free Sample
Market Dynamics
The Increasing Market Developments are Driving the Global Isothermal Nucleic Acid Amplification Technology Market Growth in the Forecast Period.
The increasing market developments such as collaborations, product launches, product approvals, mergers, expansions, partnerships, acquisitions and investments among others are driving the global isothermal nucleic acid amplification technology market growth during the forecast period.
For instance, in August 2022, LGC Clinical Diagnostics, a corporation involved in designing and manufacturing an exhaustive portfolio of catalog and custom-designed diagnostic grade solutions, biological and reagent constituent elements for the comprehensive life sciences enterprise, extended their exclusive alliance with Stanford Medicine's Department of Obstetrics and Gynecology and Metabolic Health Center sustaining multinational metabolic and genetic diagnostic examination.
The Limitations of Amplification Technology Hamper the Global Isothermal Nucleic Acid Amplification Technology Market Growth.
The limitations of amplification technology hamper the global market growth during the forecast period. For instance, limitations of amplification technology include false-positive and false-negative outcomes, the hardship of acquiring quantitative outcomes, the issue of utilizing this technology for vulnerability testing and the problem of identifying routinely the broad spectrum of potential pathogens contained in a clinical sample.
Market Segmentation Analysis
The global isothermal nucleic acid amplification technology market is segmented based on product type, applications, technology and region.
The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period
Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables, and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.
Market Geographical Share
North America Holds the Largest Share of the Global Isothermal Nucleic Acid Amplification Technology Market
North America is estimated to hold around 42.7% of the global isothermal nucleic acid amplification technology market owing to the increasing cancer cases and growing cancer research funding in this region. For instance, established on American Cancer Society data for 2023, there are around 1,958,310 new cancer cases and 609,820 cancer deaths anticipated to be in the United States.
Moreover, as part of a longstanding collaboration, the Bren Simon Comprehensive Cancer Center and Indiana University Melvin have obtained fresh and continued grants from the American Cancer Society to sustain research and schooling schedules. IU cancer investigators are presently accepting over USD 6 million in multi-year ACS grants across the Bloomington and Indianapolis campuses.
Isothermal Nucleic Acid Amplification Technology Companies
The major global players in the market include bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited, and Thermo Fisher Scientific among others.
Russia-Ukraine War Impact Analysis
The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.
Global Recession Impact Analysis
The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.
The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.
Artificial Intelligence Impact Analysis
Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.
Key Developments
- In May 2022, bioMérieux, a French multinational biotechnology corporation, completed the acquisition of Specific Diagnostics, a medical device corporation.
- In May 2022, Meridian Bioscience, a leading multinational provider of life science raw materials and diagnostic solutions, introduced two new innovative isothermal amplification developments, Lyo-Ready Direct DNA LAMP Saliva Mix and Lyo-Ready Direct RNA/DNA LAMP saliva mix, intended to be employed in point of care diagnostics assays.
- In May 2022, ThermoFisher, an American supplier of scientific instrumentation, reagents, consumables, and software services, partnered with LabShares to support the Greater Boston biotech ecosystem.
Why Purchase the Report?
- To visualize the global isothermal nucleic acid amplification technology market segmentation based on product type, applications, technology, end user, and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of isothermal nucleic acid amplification technology market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.
Target Audience 2024
- Manufacturers / Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies